These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 34386428)
1. Identification of a Four Hypoxia-Associated Long Non-Coding RNA Signature and Establishment of a Nomogram Predicting Prognosis of Clear Cell Renal Cell Carcinoma. Chen H; Pan Y; Jin X; Chen G Front Oncol; 2021; 11():713346. PubMed ID: 34386428 [TBL] [Abstract][Full Text] [Related]
2. A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma. Jiang W; Guo Q; Wang C; Zhu Y Cancer Cell Int; 2019; 19():208. PubMed ID: 31404170 [TBL] [Abstract][Full Text] [Related]
3. Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma. Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M Front Oncol; 2021; 11():663263. PubMed ID: 34123820 [TBL] [Abstract][Full Text] [Related]
4. Development and validation of a novel 5 cuproptosis-related long noncoding RNA signature to predict diagnosis, prognosis, and drug therapy in clear cell renal cell carcinoma. Chen Y; Hu W; Wei X; Zhang L; Shao Y; Tian J; Wang D; Wu B Transl Androl Urol; 2023 Apr; 12(4):622-641. PubMed ID: 37181235 [TBL] [Abstract][Full Text] [Related]
5. Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma. Su Y; Zhang T; Tang J; Zhang L; Fan S; Zhou J; Liang C Front Oncol; 2021; 11():640150. PubMed ID: 33869028 [TBL] [Abstract][Full Text] [Related]
6. HAGLR, A Long Non-coding RNA of Potential Tumor Suppressive Function in Clear Cell Renal Cell Carcinoma: Diagnostic and Prognostic Implications. Bardhan A; Banerjee A; Pal DK; Ghosh A Mol Biotechnol; 2024 Dec; 66(12):3485-3497. PubMed ID: 37955777 [TBL] [Abstract][Full Text] [Related]
7. Analysis of Ferroptosis-Related LncRNAs Signatures Associated with Tumor Immune Infiltration and Experimental Validation in Clear Cell Renal Cell Carcinoma. Chen X; Tu J; Ma L; Huang Y; Yang C; Yuan X Int J Gen Med; 2022; 15():3215-3235. PubMed ID: 35342303 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of necroptosis-related long noncoding RNA to predict prognosis, immune status, and immunotherapeutic response in clear cell renal cell carcinoma. Tang H; Chen H; Yuan H; Jin X; Chen G Transl Cancer Res; 2022 Dec; 11(12):4254-4271. PubMed ID: 36644185 [TBL] [Abstract][Full Text] [Related]
9. Identification and Validation of a Ferroptosis-Related Long Non-Coding RNA (FRlncRNA) Signature to Predict Survival Outcomes and the Immune Microenvironment in Patients With Clear Cell Renal Cell Carcinoma. Zhou Z; Yang Z; Cui Y; Lu S; Huang Y; Che X; Yang L; Zhang Y Front Genet; 2022; 13():787884. PubMed ID: 35350243 [No Abstract] [Full Text] [Related]
10. A long non-coding RNA signature to improve prognostic prediction in clear cell renal cell carcinoma. Zhang J; Zhang X; Piao C; Bi J; Zhang Z; Li Z; Kong C Biomed Pharmacother; 2019 Oct; 118():109079. PubMed ID: 31351427 [TBL] [Abstract][Full Text] [Related]
11. Identification of a Three-Glycolysis-Related lncRNA Signature Correlated With Prognosis and Metastasis in Clear Cell Renal Cell Carcinoma. Li T; Tong H; Zhu J; Qin Z; Yin S; Sun Y; Liu X; He W Front Med (Lausanne); 2021; 8():777507. PubMed ID: 35083240 [TBL] [Abstract][Full Text] [Related]
12. A Panel of Four-lncRNA Signature as a Potential Biomarker for Predicting Survival in Clear Cell Renal Cell Carcinoma. Liu H; Ye T; Yang X; Lv P; Wu X; Zhou H; Zeng J; Tang K; Ye Z J Cancer; 2020; 11(14):4274-4283. PubMed ID: 32368310 [TBL] [Abstract][Full Text] [Related]
13. Long Non-Coding RNA Profile Study Identifies an Immune-Related lncRNA Prognostic Signature for Kidney Renal Clear Cell Carcinoma. Sun Z; Jing C; Xiao C; Li T Front Oncol; 2020; 10():1430. PubMed ID: 32974157 [TBL] [Abstract][Full Text] [Related]
14. N6-Methyladenosine-Related Long Non-coding RNA Signature Associated With Prognosis and Immunotherapeutic Efficacy of Clear-Cell Renal Cell Carcinoma. Ma T; Wang X; Wang J; Liu X; Lai S; Zhang W; Meng L; Tian Z; Zhang Y Front Genet; 2021; 12():726369. PubMed ID: 34721523 [TBL] [Abstract][Full Text] [Related]
15. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
16. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients. He Y; Ye Y; Tian W; Qiu H Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662 [No Abstract] [Full Text] [Related]
17. A Model to Predict Prognosis of Renal Cell Clear Cell Carcinoma Based on 3 Angiogenesis-related Long Non-coding RNAs. Chen G; Zhang T; Li F; Cui C; Huang Z; Gou X; Song Y; Li Y J Cancer; 2024; 15(11):3481-3494. PubMed ID: 38817877 [No Abstract] [Full Text] [Related]
18. A five-long non-coding RNA signature to improve prognosis prediction of clear cell renal cell carcinoma. Shi D; Qu Q; Chang Q; Wang Y; Gui Y; Dong D Oncotarget; 2017 Aug; 8(35):58699-58708. PubMed ID: 28938589 [TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma. Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382 [TBL] [Abstract][Full Text] [Related]
20. Genome-wide screening and cohorts validation identifying novel lncRNAs as prognostic biomarkers for clear cell renal cell carcinoma. Zhang C; Huang D; Liu A; Xu Y; Na R; Xu D J Cell Biochem; 2020 Mar; 121(3):2559-2570. PubMed ID: 31646670 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]